{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:27:29Z","timestamp":1718411249161},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"DOI":"10.7759\/cureus.62380","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:39:35Z","timestamp":1718375975000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Shen Cao Gan Jiang Tang on Non-severe COVID-19 Patients: A Multicenter, Randomized, Open-Label Clinical Trial"],"prefix":"10.7759","author":[{"given":"Dieu-Thuong Thi","family":"Trinh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An Hoa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh-Man Pham","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thy Xuan","family":"Kieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van-Dan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Huu Lac","family":"Thuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khac-Minh","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Lam","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-1597","article-title":"Recommendations for the management of COVID-19 in low- and middle-income countries","volume":"104","author":"Dondorp AM","year":"2021","unstructured":"Dondorp AM, Papali AC, Schultz MJ. Recommendations for the management of COVID-19 in low- and middle-income countries. Am J Trop Med Hyg. 2021, 104:1-2. 10.4269\/ajtmh.20-1597","journal-title":"Am J Trop Med Hyg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153308","article-title":"Prevention and treatment of COVID-19 using traditional chinese medicine: a review","volume":"85","author":"Zhao Z","year":"2021","unstructured":"Zhao Z, Li Y, Zhou L, Zhou X, Xie B, Zhang W, Sun J. Prevention and treatment of COVID-19 using traditional chinese medicine: a review. Phytomedicine. 2021, 85:153308. 10.1016\/j.phymed.2020.153308","journal-title":"Phytomedicine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-020-3192-6","article-title":"Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs","volume":"26","author":"Luo H","year":"2020","unstructured":"Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, Liu JP. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020, 26:243-50. 10.1007\/s11655-020-3192-6","journal-title":"Chin J Integr Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104743","article-title":"Traditional Chinese medicine for COVID-19 treatment","volume":"155","author":"Ren JL","year":"2020","unstructured":"Ren JL, Zhang AH, Wang XJ. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020, 155:104743. 10.1016\/j.phrs.2020.104743","journal-title":"Pharmacol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153337","article-title":"Traditional Chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis","volume":"80","author":"Lee DY","year":"2021","unstructured":"Lee DY, Li QY, Liu J, Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis. Phytomedicine. 2021, 80:153337. 10.1016\/j.phymed.2020.153337","journal-title":"Phytomedicine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4703632","article-title":"Simultaneous Determination of 8 Compounds in Gancao-Ganjiang-Tang by HPLC-DAD and analysis of the relations between compatibility, dosage, and contents of medicines","volume":"2017","author":"Yang Y","year":"2017","unstructured":"Yang Y, Zhang G, Sun Q, Liu L, Peng H, Wang J, Xiang L. Simultaneous Determination of 8 Compounds in Gancao-Ganjiang-Tang by HPLC-DAD and analysis of the relations between compatibility, dosage, and contents of medicines. Evid Based Complement Alternat Med. 2017, 2017:4703632. 10.1155\/2017\/4703632","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153476","article-title":"Toxicity as prime selection criterion among SARS-active herbal medications","volume":"85","author":"Oesch F","year":"2021","unstructured":"Oesch F, Oesch-Bartlomowicz B, Efferth T. Toxicity as prime selection criterion among SARS-active herbal medications. Phytomedicine. 2021, 85:153476. 10.1016\/j.phymed.2021.153476","journal-title":"Phytomedicine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz KF","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340:c332. 10.1136\/bmj.c332","journal-title":"BMJ"},{"key":"ref9","article-title":"World Health Organization: COVID\u201019 clinical management: living guidance","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. COVID\u201019 Clinical Management: Living Guidance 25 January 2021. World Health Organization, 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/338882\/WHO-2019-nCoV-clinical-2021.1-eng.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.51298\/vmj.v520i1B.3851","article-title":"Evaluate acute toxicity and semi-permanent toxicity of Shen Cao Gan Jiang Tang (Sam Thao Can Khuong Thang) [Article in Vietnamese]","volume":"520","author":"Thu\u1ef7 NH","year":"2022","unstructured":"Thu\u1ef7 NH, Nh\u1ef1t TM, Th\u01b0\u1eddng TT. Evaluate acute toxicity and semi-permanent toxicity of Shen Cao Gan Jiang Tang (Sam Thao Can Khuong Thang) [Article in Vietnamese]. Vietnam Med J. 2022, 520:119-23. 10.51298\/vmj.v520i1B.3851","journal-title":"Vietnam Med J"},{"key":"ref11","article-title":"Vietnam Ministry of Health. Guidelines for diagnosis and treatment of new corona virus (SARS-CoV-2) COVID-19. Decision number 3416\/Q\u0110-BYT dated July 14th","author":"Vietnam Ministry of Health","year":"2021","unstructured":"Vietnam Ministry of Health. Guidelines for Diagnosis and Treatment of New Coronavirus (SARS-CoV-2) COVID-19. Vietnam Ministry of Health, Hanoi; 2021."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153242","article-title":"Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial","volume":"85","author":"Hu K","year":"2021","unstructured":"Hu K, Guan WJ, Bi Y, et al.. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2021, 85:153242. 10.1016\/j.phymed.2020.153242","journal-title":"Phytomedicine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153390","article-title":"Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study","volume":"85","author":"Xia L","year":"2021","unstructured":"Xia L, Shi Y, Su J, et al.. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021, 85:153390. 10.1016\/j.phymed.2020.153390","journal-title":"Phytomedicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7141","article-title":"Efficacy and safety of Xiyanping injection in the treatment of COVID-19: a multicenter, prospective, open-label and randomized controlled trial","volume":"35","author":"Zhang XY","year":"2021","unstructured":"Zhang XY, Lv L, Zhou YL, et al.. Efficacy and safety of Xiyanping injection in the treatment of COVID-19: a multicenter, prospective, open-label and randomized controlled trial. Phytother Res. 2021, 35:4401-10. 10.1002\/ptr.7141","journal-title":"Phytother Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105126","article-title":"Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial","volume":"161","author":"Xiao M","year":"2020","unstructured":"Xiao M, Tian J, Zhou Y, et al.. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial. Pharmacol Res. 2020, 161:105126. 10.1016\/j.phrs.2020.105126","journal-title":"Pharmacol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13614","article-title":"Chinese herbal medicine (\"3 medicines and 3 formulations\") for COVID-19: rapid systematic review and meta-analysis","volume":"28","author":"Wang Y","year":"2022","unstructured":"Wang Y, Greenhalgh T, Wardle J. Chinese herbal medicine (\"3 medicines and 3 formulations\") for COVID-19: rapid systematic review and meta-analysis. J Eval Clin Pract. 2022, 28:13-32. 10.1111\/jep.13614","journal-title":"J Eval Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-2121","article-title":"Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study","volume":"10","author":"Xu X","year":"2021","unstructured":"Xu X, Zhang J, Zheng W, et al.. Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study. Ann Palliat Med. 2021, 10:5146-55. 10.21037\/apm-20-2121","journal-title":"Ann Palliat Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153494","article-title":"Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients","volume":"84","author":"Devpura G","year":"2021","unstructured":"Devpura G, Tomar BS, Nathiya D, et al.. Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients. Phytomedicine. 2021, 84:153494. 10.1016\/j.phymed.2021.153494","journal-title":"Phytomedicine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05583-0","article-title":"Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India","volume":"22","author":"Natarajan S","year":"2021","unstructured":"Natarajan S, Anbarasi C, Sathiyarajeswaran P, et al.. Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India. Trials. 2021, 22:623. 10.1186\/s13063-021-05583-0","journal-title":"Trials"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05478-0","article-title":"Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial","volume":"22","author":"Srivastava A","year":"2021","unstructured":"Srivastava A, Rengaraju M, Srivastava S, et al.. Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial. Trials. 2021, 22:570. 10.1186\/s13063-021-05478-0","journal-title":"Trials"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7277","article-title":"Efficacy of Persian medicine herbal formulations (capsules and\u00a0decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial","volume":"35","author":"Karimi M","year":"2021","unstructured":"Karimi M, Zarei A, Soleymani S, et al.. Efficacy of Persian medicine herbal formulations (capsules and\u00a0decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial. Phytother Res. 2021, 35:6295-309. 10.1002\/ptr.7277","journal-title":"Phytother Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7669","article-title":"Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Jin D","year":"2023","unstructured":"Jin D, Wang J, Xue J, Zhao Y, Yan G, Li X, Wang X. Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2023, 37:1015-35. 10.1002\/ptr.7669","journal-title":"Phytother Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.09.008","article-title":"Traditional Chinese medicine in COVID-19","volume":"11","author":"Lyu M","year":"2021","unstructured":"Lyu M, Fan G, Xiao G, et al.. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B. 2021, 11:3337-63. 10.1016\/j.apsb.2021.09.008","journal-title":"Acta Pharm Sin B"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06376-1","article-title":"COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study","volume":"21","author":"Abdulrahman A","year":"2021","unstructured":"Abdulrahman A, Mallah SI, Alqahtani M. COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infect Dis. 2021, 21:688. 10.1186\/s12879-021-06376-1","journal-title":"BMC Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v10.i4.132","article-title":"SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: a systematic review","volume":"10","author":"Shenoy S","year":"2021","unstructured":"Shenoy S. SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: a systematic review. World J Crit Care Med. 2021, 10:132-50. 10.5492\/wjccm.v10.i4.132","journal-title":"World J Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/2515690X21996662","article-title":"Licorice: a potential herb in overcoming SARS-CoV-2 infections","volume":"26","author":"Ng SL","year":"2021","unstructured":"Ng SL, Khaw KY, Ong YS, et al.. Licorice: a potential herb in overcoming SARS-CoV-2 infections. J Evid Based Integr Med. 2021, 26:2515690X21996662. 10.1177\/2515690X21996662","journal-title":"J Evid Based Integr Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-020-00171-6","article-title":"Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda","volume":"7","author":"Haridas M","year":"2021","unstructured":"Haridas M, Sasidhar V, Nath P, Abhithaj J, Sabu A, Rammanohar P. Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda. Futur J Pharm Sci. 2021, 7:13. 10.1186\/s43094-020-00171-6","journal-title":"Futur J Pharm Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1778539","article-title":"Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach","volume":"39","author":"Chikhale RV","year":"2021","unstructured":"Chikhale RV, Gurav SS, Patil RB, et al.. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J Biomol Struct Dyn. 2021, 39:4510-21. 10.1080\/07391102.2020.1778539","journal-title":"J Biomol Struct Dyn"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154136","article-title":"Herbal medicine for COVID-19: an overview of systematic reviews and meta-analysis","volume":"102","author":"Ang L","year":"2022","unstructured":"Ang L, Song E, Zhang J, Lee HW, Lee MS. Herbal medicine for COVID-19: an overview of systematic reviews and meta-analysis. Phytomedicine. 2022, 102:154136. 10.1016\/j.phymed.2022.154136","journal-title":"Phytomedicine"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2031274","article-title":"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines","volume":"54","author":"Fernandes Q","year":"2022","unstructured":"Fernandes Q, Inchakalody VP, Merhi M, et al.. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022, 54:524-40. 10.1080\/07853890.2022.2031274","journal-title":"Ann Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243709-efficacy-of-shen-cao-gan-jiang-tang-on-non-severe-covid-19-patients-a-multicenter-randomized-open-label-clinical-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:39:38Z","timestamp":1718375978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243709-efficacy-of-shen-cao-gan-jiang-tang-on-non-severe-covid-19-patients-a-multicenter-randomized-open-label-clinical-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.62380","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}